The infusion of USD 350 million in early-stage venture funding in 2025 highlights investor confidence in reproductive technology innovation. Private equity participation in emerging infusion catheters and embryo monitoring devices has accelerated market dynamics. https://www.patreon.com/posts/infertility-by-131372884